190 related articles for article (PubMed ID: 23033969)
1. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
[TBL] [Abstract][Full Text] [Related]
3. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
[TBL] [Abstract][Full Text] [Related]
4. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
Kadoglou NP; Gerasimidis T; Moumtzouoglou A; Kapelouzou A; Sailer N; Fotiadis G; Vitta I; Katinios A; Kougias P; Bandios S; Voliotis K; Karayannacos PE; Liapis CD
Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):661-8. PubMed ID: 18395477
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.
Marchione P; Vento C; Morreale M; Izzo C; Maugeri A; Manuppella F; Romeo T; Giacomini P
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):138-43. PubMed ID: 25440329
[TBL] [Abstract][Full Text] [Related]
6. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk.
Kadoglou NP; Vrabas IS; Kapelouzou A; Lampropoulos S; Sailer N; Kostakis A; Liapis CD
Regul Pept; 2011 Oct; 170(1-3):57-61. PubMed ID: 21640762
[TBL] [Abstract][Full Text] [Related]
7. Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure.
Liakos CI; Sanidas EA; Perrea DN; Grassos CA; Chantziara V; Viniou NA; Barbetseas JD; Papadopoulos DP
Am J Hypertens; 2016 May; 29(5):549-52. PubMed ID: 26276791
[TBL] [Abstract][Full Text] [Related]
8. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
Kadoglou NP; Gerasimidis T; Kapelouzou A; Moumtzouoglou A; Avgerinos ED; Kakisis JD; Karayannacos PE; Liapis CD
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):258-65. PubMed ID: 20004120
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
[TBL] [Abstract][Full Text] [Related]
11. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
[TBL] [Abstract][Full Text] [Related]
13. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability.
Kadoglou NP; Lambadiari V; Gastounioti A; Gkekas C; Giannakopoulos TG; Koulia K; Maratou E; Alepaki M; Kakisis J; Karakitsos P; Nikita KS; Dimitriadis G; Liapis CD
Atherosclerosis; 2014 Aug; 235(2):606-12. PubMed ID: 24956535
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
[TBL] [Abstract][Full Text] [Related]
15. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
[TBL] [Abstract][Full Text] [Related]
16. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study.
Della-Morte D; Moussa I; Elkind MS; Sacco RL; Rundek T
Neurol Res; 2011 Nov; 33(9):991-4. PubMed ID: 22081003
[TBL] [Abstract][Full Text] [Related]
17. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
Hsu HY; Wang PY; Chen YT; Sheu WH; Hu HH; Sheng WY
J Chin Med Assoc; 2005 Feb; 68(2):53-8. PubMed ID: 15759815
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
19. Omentin-1 and vaspin serum levels in patients with pre-clinical carotid atherosclerosis and the effect of statin therapy on them.
Kadoglou NPE; Kassimis G; Patsourakos N; Kanonidis I; Valsami G
Cytokine; 2021 Feb; 138():155364. PubMed ID: 33338917
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study.
Kadoglou NP; Gkontopoulos A; Kapelouzou A; Fotiadis G; Theofilogiannakos EK; Kottas G; Lampropoulos S
Clin Chim Acta; 2011 Jan; 412(1-2):48-52. PubMed ID: 20850423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
